Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT05520567 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | January 26, 2026 (Jan 26, 2026) |
As of March 2, 2026: Clinical trial NCT05520567 is currently recruiting participants. This clinical trial study for acute myeloid leukemia is actively seeking new participants at 20 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05520567 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05520567 was last updated Jan 26, 2026 (January 26, 2026). HelloStudys verifies this status automatically.